This is the largest study in this field worldwide and was led by the Liver Oncology Unit (BCLC) at Clínic-IDIBAPS, within the Clínic Barcelona Comp...
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clín...
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer...
The European Association for the Study of the Liver (EASL) has published an update of its guidelines for the management of hepatocellular carcinoma...
Last week, an event was held in Barcelona by the Association Against Cancer (AECC) to present the Research Grants 2023 that will be carried out in...
Researchers from the Hospital Clínic-IDIBAPS have participated in the preparation of the new guidelines on intrahepatic cholangiocarcinoma, the sec...
The mortality rate during the first month of infection for patients with advanced-stage hepatocellular carcinoma rose to 20.7%.
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit
